BioSpace News Archive

Roche’s Rozlytrek Hits Milestone with Approval in Japan

Rozlytrek is the first tumor-agnostic medicine approved in Japan for adult and pediatric patients with NTRK fusion-positive advanced recurrent solid tumors.

June 18, 2019
·
3 min read
·
Alex Keown
Business

Sanofi and Google Partner on Digital Health and Real-World Evidence Analysis

Google and Sanofi are partnering to set up a new virtual innovation lab with a focus on data technologies and digital health. The goal is to change how Sanofi develops new drugs.

June 18, 2019
·
3 min read
·
Mark Terry
Policy

Only Half of Post-Marketing Commitments Get Published in Peer-Reviewed Journals, Study Shows

Transparency in clinical trials has been a concern and the new study highlights the continued issue.

June 18, 2019
·
2 min read
·
Alex Keown
Business

Amgen’s deCODE and Intermountain Healthcare to Run 500,000 Patient DNA Study

Amgen hopes the data will provide insights into specific diseases that will help develop new drugs.

June 18, 2019
·
2 min read
·
Mark Terry
Business

The Importance of Increasing Diversity in Genetic Research

The advent of increasingly more mainstream and affordable genetic testing enables powerful genetic research – but that power is directly associated with the strength and diversity of the database of genetic information available.

June 18, 2019
·
6 min read
·
Chelsea Weidman Burke
Business

SpringWorks and BeiGene Team Up to Form New Company

The companies will combine their research expertise to develop BGB-3245, an investigational, oral, selective small molecule inhibitor of monomer and dimer forms of activating B-RAF mutations including V600 BRAF mutations, non-V600 B-RAF mutations, and RAF fusions.

June 18, 2019
·
2 min read
·
Alex Keown
Policy

India’s Pharmaceutical Business Could Benefit from the Sino-American Trade Conflict

Trade tensions between Washington, D.C. and Beijing continue, but have not yet impacted the pharmaceutical products traded between the two countries. However, if the punitive tariffs continue and pharma is impacted, a third global player could step in to fill the void in both countries.

June 18, 2019
·
3 min read
·
Alex Keown
Policy

Singapore Scientists Discover New Viruses That Identifies High-Risk Individuals Of Cantonese Cancer

Scientists from the Agency for Science, Technology and Research’s Genome Institute of Singapore have identified two new Epstein-Barr Virus viral variants associated with cancers, including nasopharyngeal carcinoma, gastric cancer, and several kinds of lymphomas[2].

June 18, 2019
·
6 min read
Business

Vivoryon Therapeutics mandates goetzpartners as strategic business development advisor for expansion of its innovative QPCTL technology into immuno-oncology

Vivoryon Therapeutics AG and goetzpartners, announced their collaboration to explore the expansion of Vivoryon’s proprietary platform based on its Glutaminyl-peptide cyclotransferase-like protein technology into the field of immuno-oncology.

June 18, 2019
·
6 min read
Althea Achieves 1,000 Patient Milestone

Australian medicinal cannabis company Althea Group Holdings Limited is pleased to provide the following update regarding the uptake of its medicinal cannabis products in Australia.

June 18, 2019
·
3 min read